Tien Q. Nguyen - Jul 31, 2025 Form 4 Insider Report for Expion360 Inc. (XPON)

Role: Director
Signature: /s/ Brian Schaffner, Attorney-in-Fact for Tien Q. Nguyen
Stock symbol: XPON
Transactions as of: Jul 31, 2025
Transactions value $: $0
Form type: 4
Date filed: 8/1/2025, 09:58 PM
Previous filing: Aug 28, 2023
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Nguyen Tien Quoc	Director	2025 SW DEERHOUND AVE, REDMOND	/s/ Brian Schaffner, Attorney-in-Fact for Tien Q. Nguyen	2025-08-01	0001991527

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XPON	Common Stock	Award	$0	+5K	+97.62%	$0.00	10.1K	Jul 31, 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XPON	Stock Option (Right to Buy)	Award	$0	+5K		$0.00	5K	Jul 31, 2025	Common Stock	5K	$0.93	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs vested in full on July 31, 2025.
F2	Includes (i) 122 shares of Common Stock, (ii) 5,000 RSUs, which were granted to the Reporting Person on July 31, 2025 as reported herein, and (iii) 5,000 shares of Common Stock, which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of July 31, 2025.
F3	The exercise price of the Options (as defined below) was determined based on the closing price of the Common Stock on the date the Options were conditionally approved by the board of directors.
F4	Reflects a grant of stock options (the "Options") made to the Reporting Person under the Plan. The Options were approved by the board of directors on April 28, 2025, subject to stockholder approval of an increase in the number of shares available for issuance under the Plan under which the Options were granted (the "Plan Amendment"). The Plan Amendment was approved by stockholders on July 31, 2025. The Options vested in full and became immediately exercisable on July 31, 2025.